ESC Premium Access

Plasma levels of ST2 - predictive factor of unfavourable outcome in hypertensive patients

Congress Presentation

About the speaker

Doctor Anca Daniela Farcas

University of Medicine and Pharmacy of Cluj Napoca, Cluj Napoca (Romania)
0 follower

9 more presentations in this session

Rates of adherence to modern antihypertensive drugs in resistant hypertension

Speaker: Doctor E. Kocianova (Olomouc, CZ)


Non-steroid anti-inflammatory drug consumption decrease antihypertensive treatment efficacy in postenopausal women

Speaker: Professor N. Izmozherova (Yekaterinburg, RU)


Long-term treatment with LCZ696 (sacubitril/valsartan) improves cardiac and renal function in stroke-prone spontaneously hypertensive rats

Speaker: Professor Y. Takeda (Ishikawa, JP)


Effect of perindopril/indapamide/amlodipine fixed-dose combination on peripheral and central hemodynamics and vascular wall stiffness parameters in patients with uncontrolled hypertension

Speaker: Doctor T. Netchessova (Minsk, BY)


CHINA STudy of valsartan/amlodipine fixed-dose combination-bAsed long-Term blood pressUre management in HypertenSive Patients: A one-year registry (CHINA STATUS III)

Speaker: Mr Z. Du (Beijing, CN)


Access the full session

Poster Session 2 - Hypertension treatment old and new

Speakers: Doctor A. Farcas, Doctor E. Kocianova, Professor N. Izmozherova, Professor Y. Takeda, Doctor T. Netchessova...

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb